연구동향 분석

Comparison of Full Lesion Coverage versus Spot Drug-Eluting Stent Implantation for Coronary Artery Stenoses

김승환 홍명기 윤경호 강웅철 신동호 김중선 김병극 고영국 최동훈 장양수 2014년

논문상세정보
인용/피인용
' Comparison of Full Lesion Coverage versus Spot Drug-Eluting Stent Implantation for Coronary Artery Stenoses' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • coronary artery disease
  • drug-elutingstents
  • percutaneous coronary intervention
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,726 0

0.0%

' Comparison of Full Lesion Coverage versus Spot Drug-Eluting Stent Implantation for Coronary Artery Stenoses' 의 참고문헌

  • Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry
    Abbott JD J Am Coll Cardiol 50 2029-2036 [2007]
  • The relationship and threshold of stent length with regard to risk of stent thrombosis after drug-eluting stent implantation
    Suh J JACC Cardiovasc Interv 3 383-389 [2010]
  • The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS)
    Schampaert E J Am Coll Cardiol 43 1110-1115 [2004]
  • TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions
    Grube E Eur Heart J 28 2578-2582 [2007]
  • Stented segment length as an independent predictor of restenosis
    Kobayashi Y J Am Coll Cardiol 34 651-659 [1999]
  • Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)
    Schofer J Lancet 362 1093-1099 [2003]
  • Shortening the stent length reduces restenosis with bare metal stents: matched pair comparison of short stenting and conventional stenting
    Dietz U Heart 92 80-84 [2006]
  • Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial)
    Sakurai R Am J Cardiol 96 1251-1253 [2005]
  • Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry
    Williams DO Circulation 114 2154-2162 [2006]
  • Optimal medical therapy with or without PCI for stable coronary disease
    Boden WE N Engl J Med 356 1503-1516 [2007]
  • Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery
    Tsagalou E J Am Coll Cardiol 45 1570-1573 [2005]
  • Intravascular ultrasound-guided percutaneous transluminal coronary angioplasty with provisional spot stenting for treatment of long coronary lesions
    Colombo A J Am Coll Cardiol 38 1427-1433 [2001]
  • Influence of lesion length on restenosis after coronary stent placement
    Kastrati A Am J Cardiol 83 1617-1622 [1999]
  • Incidence and predictors of very late (>or=4 years) major cardiac adverse events in the DESIRE (Drug-Eluting Stents in the Real World)-Late registry
    Costa JR Jr JACC Cardiovasc Interv 3 12-18 [2010]
  • Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation
    Räber L J Am Coll Cardiol 55 1178-1188 [2010]
  • Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry)
    Caputo RP Am J Cardiol 110 350-355 [2012]
  • Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial
    Bech GJ Circulation 103 2928-2934 [2001]
  • Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos)
    de la Torre-Hernández JM J Am Coll Cardiol 51 986-990 [2008]
  • Comparison of long versus short (“spot”) drug-eluting stenting for long coronary stenoses
    Katritsis DG Am J Cardiol 104 786-790 [2009]
  • Comparison of angiographic patterns of in-stent restenosis between sirolimus- and paclitaxel-eluting stent
    Park CB Int J Cardiol 120 387-390 [2007]
  • Clinical end points in coronary stent trials: a case for standardized definitions
    Cutlip DE Circulation 115 2344-2351 [2007]
  • An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents
    Liu J Am J Cardiol 103 501-506 [2009]
  • A New Strategy for Discontinuation of Dual Antiplatelet Therapy: The RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation).
    Kim BK JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 60 15 1340-1348 [2012]